title: Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.
abstract: Excess of body fat, or obesity, is a major health problem and confers a higher risk of cardiovascular and metabolic disorders such as diabetes, hypertension, and coronary heart disease. Leptin is an adipocyte-derived satiety factor that plays an important role in the regulation of energy homeostasis, and its synthesis and secretion are markedly increased in obese subjects. To explore the metabolic consequences of an increased amount of leptin on a long-term basis in vivo, we generated transgenic skinny mice with elevated plasma leptin concentrations comparable to those in obese subjects. Overexpression of leptin in the liver has resulted in complete disappearance of white and brown adipose tissue for a long period of time in mice. Transgenic skinny mice exhibit increased glucose metabolism accompanied by the activation of insulin signaling in the skeletal muscle and liver. They also show small-sized livers with a marked decrease in glycogen and lipid storage. The phenotypes are in striking contrast to those of recently reported animal models of lipoatrophic diabetes and patients with lipoatrophic diabetes with reduced amount of leptin. The present study provides evidence that leptin is an adipocyte-derived antidiabetic hormone in vivo and suggests its pathophysiologic and therapeutic implications in diabetes.
authors.affiliation: Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Japan. ogawa@kuhp.kyoto-u.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Ogawa
authors.forename: H
authors.initials: H
authors.lastname: Masuzaki
authors.forename: K
authors.initials: K
authors.lastname: Hosoda
authors.forename: M
authors.initials: M
authors.lastname: Aizawa-Abe
authors.forename: J
authors.initials: J
authors.lastname: Suga
authors.forename: M
authors.initials: M
authors.lastname: Suda
authors.forename: K
authors.initials: K
authors.lastname: Ebihara
authors.forename: H
authors.initials: H
authors.lastname: Iwai
authors.forename: N
authors.initials: N
authors.lastname: Matsuoka
authors.forename: N
authors.initials: N
authors.lastname: Satoh
authors.forename: H
authors.initials: H
authors.lastname: Odaka
authors.forename: H
authors.initials: H
authors.lastname: Kasuga
authors.forename: Y
authors.initials: Y
authors.lastname: Fujisawa
authors.forename: G
authors.initials: G
authors.lastname: Inoue
authors.forename: H
authors.initials: H
authors.lastname: Nishimura
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshimasa
authors.forename: K
authors.initials: K
authors.lastname: Nakao
mesh_terms: D000818:Animals; D001835:Body Weight / Q000502:physiology*; D005260:Female; D005947:Glucose / Q000378:metabolism*; D007333:Insulin Resistance; D020738:Leptin; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D008112:Liver Glycogen / Q000378:metabolism; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009765:Obesity / Q000097:blood; D014176:Protein Biosynthesis; D015398:Signal Transduction / Q000502:physiology
chemical_list: D020738:Leptin; D008112:Liver Glycogen; D005947:Glucose